| 000 | 01679 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515191620.0 | ||
| 264 | 0 | _c20100219 | |
| 008 | 201002s 0 0 eng d | ||
| 022 | _a1468-2060 | ||
| 024 | 7 |
_a10.1136/ard.2009.117762 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMariette, X | |
| 245 | 0 | 0 |
_aLymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry. _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cFeb 2010 |
||
| 300 |
_a400-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 |
_aArthritis _xdrug therapy |
| 650 | 0 | 4 | _aEpidemiologic Methods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFrance _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aLymphoma _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aTubach, F | |
| 700 | 1 | _aBagheri, H | |
| 700 | 1 | _aBardet, M | |
| 700 | 1 | _aBerthelot, J M | |
| 700 | 1 | _aGaudin, P | |
| 700 | 1 | _aHeresbach, D | |
| 700 | 1 | _aMartin, A | |
| 700 | 1 | _aSchaeverbeke, T | |
| 700 | 1 | _aSalmon, D | |
| 700 | 1 | _aLemann, M | |
| 700 | 1 | _aHermine, O | |
| 700 | 1 | _aRaphael, M | |
| 700 | 1 | _aRavaud, P | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 69 _gno. 2 _gp. 400-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.2009.117762 _zAvailable from publisher's website |
| 999 |
_c19221923 _d19221923 |
||